Structural Figure (Zomig Tablets Avema New2 1)
Zomig Tablet, Film Coated
Product Images NDC 60846-133
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zomig (NDC 60846-133). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Zomig Tablets Avema New2 2)
Estimated Probability of Response for different doses of Zomig over time from the initial dose, including placebo. The text indicates percentages for response rates at different time points.*
Figure 2 (Zomig Tablets Avema New2 3)
This text provides information about the estimated probability of remedic over time, measured in hours from the initial dose. The values for probable remedic are also mentioned at different time intervals.*
2-5 Ifc (Zomig Tablets Avema New2 4)
This is a description for Zomig Tablets, which contain zolmitriptan 2.5 mg per tablet. The tablets are available in a unit dose pack with 6 tablets. The NDC for these tablets is 60846-130-30 and they are for prescription use only.*
5 Ifc (Zomig Tablets Avema New2 5)
This is a text containing information about Zolmitriptan tablets with a dosage of 5 mg. The tablets are supplied in a unit-dose packaging of 3 tablets per pack. The NDC (National Drug Code) for the product is 60846-133-60.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
